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Abstract
We consider high-dimensional regression over subgroups of observa-
tions. Our work is motivated by biomedical problems, where disease sub-
types, for example, may differ with respect to underlying regression mod-
els, but sample sizes at the subgroup-level may be limited. We focus on the
case in which subgroup-specific models may be expected to be similar but
not necessarily identical. Our approach is to treat subgroups as related
problem instances and jointly estimate subgroup-specific regression coeffi-
cients. This is done in a penalized framework, combining an `1 term with
an additional term that penalizes differences between subgroup-specific
coefficients. This gives solutions that are globally sparse but that allow
information-sharing between the subgroups. We present algorithms for
estimation and empirical results on simulated data and using Alzheimer’s
disease, amyotrophic lateral sclerosis and cancer datasets. These exam-
ples demonstrate the gains our approach can offer in terms of prediction
and the ability to estimate subgroup-specific sparsity patterns.
1 Introduction
High-dimensional regression has been well studied in the case where all samples
can reasonably be expected to follow the same model. However, in several
*Data used in preparation of this article were obtained from the Alzheimers Disease Neu-
roimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within
the ADNI contributed to the design and implementation of ADNI and/or provided data but
did not participate in analysis or writing of this report. A complete listing of ADNI investiga-
tors can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_
Acknowledgement_List.pdf
1
ar
X
iv
:1
61
1.
00
95
3v
2 
 [s
tat
.A
P]
  9
 D
ec
 20
16
current and emerging applications, observations span multiple subgroups that
may not be identical with respect to the underlying regression models. Examples
abound, from disease subtypes in biomedicine to customer subsets in business
applications. We are specifically motivated by biomedical problems, where sets
of samples, such as disease subtypes, although related, may differ with respect to
underlying biology and therefore have different relationships between covariates
and a response of interest.
Thus, we focus on high-dimensional regression in group-structured settings.
In particular, we consider linear regression in a commonly-encountered scenario
in which the same set of p covariates or predictors is available in each of K
subgroups. That is, we consider subgroup-specific linear regression problems
indexed by k, each with subgroup-specific sample size nk, a response vector
yk of length nk, a nk × p feature matrix Xk and a p-vector βk of regression
coefficients. The problem we address is estimating the regression coefficients
β1 . . . βK .
We propose an approach to jointly estimate the regression coefficients that
induces global sparsity and encourages similarity between subgroup-specific co-
efficients. We consider the following penalized formulation and its variants
Bˆ = arg min
B=[β1...βk]
K∑
k=1
{
‖yk −Xkβk‖22 + λ‖βk‖1 + γ
∑
k′>k
τk,k′‖βk − βk′‖22
}
where, B = [β1 . . . βK ] is a p×K matrix that collects together all the regression
coefficients, ‖ · ‖q denotes the `q norm of its argument and λ, γ, τ are tuning
parameters. The last term is a fusion-type penalty between subgroups; note that
the difference is taken between entire vectors of subgroup-specific coefficients.
An `2 fusion penalty is shown above, although other penalties may be used;
in this manuscript, we also consider an `1 variant. The parameters τk,k′ allow
for the possibility of controlling the extent to which similarity is encouraged for
specific pairs of subgroups.
Our proposal shares similarities with both the group lasso [Yuan and Lin,
2006] and the fused lasso [Tibshirani et al., 2005] but differs from both in im-
portant ways. In contrast to the group lasso, we consider subgroups of samples
or observations rather than groups of coefficients and in contrast to the fused
lasso, we consider fusion of entire (subgroup-specific) coefficient vectors, rather
than successive coefficients under a pre-defined ordering. Obozinski et al. [2010]
showed how the group lasso could be used in subgroup-structured settings, es-
sentially by considering the global problem and defining groups (in the group
lasso sense) corresponding to the same covariate across all subgroups. This
means that each covariate tends either to be included in all subgroup-specific
models or none. In contrast, our approach allows subgroups to have differ-
ent sparsity patterns, whilst pulling subgroup-specific coefficients together and
inducing global sparsity. Our work is also similar in spirit to recent work con-
cerning joint estimation of graphical models over multiple problem instances
[Danaher et al., 2014, Oates et al., 2014, 2015].
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We are motivated by emerging problems in biomedical research and specif-
ically in personalized medicine. High-dimensional regression problems are now
becoming common in this area, with several high-dimensional data types already
in mainstream use. In the personalized medicine setting, samples usually corre-
spond to individuals and the subgroups k to e.g. diseases or disease subtypes.
It is increasingly clear that many disease subtypes differ in their biology [see
e.g. Weinstein et al., 2013, Akbani et al., 2014], suggesting that relationships
between covariates and responses of interest may differ between them. How-
ever, sample sizes tend to be limited, especially at the subgroup level, posing
problems for the subgroup-wise strategy of solving each problem separately. On
the other hand, pooling all the data together into a single regression problem
may lead to severe mis-specification if the underlying subgroup-specific models
do indeed differ.
These issues may lead to losses in terms of predictive ability and perhaps just
as important in the ability to efficiently estimate subgroup-specific influences
that may themselves be of interest. In contrast to simple pooling, our approach
allows subgroups to have different sparsity patterns and regression coefficients,
but in contrast to the subgroup-wise approach it takes advantage of similarities
between subgroups.
We show empirical results in the context of two neurodegenerative diseases
- Alzheimer’s disease and amyotrophic lateral sclerosis (ALS) - and cancer (see
below for full details of the applications and data). The responses concern
disease progression in Alzheimer’s and ALS and therapeutic response in cancer
cell lines. In the Alzheimer’s and ALS examples, subgroups are based on clinical
factors, while in the cancer data they are based on the tissue type of the cell
lines.
Across the three examples, data types include genetic, clinical and transcrip-
tomic variables. We find that our approach can improve performance relative
to pooling or subgroup-wise analysis. Importantly, in cases where pooling or
subgroup-wise analyses do well (perhaps reflecting a lack of subgroup structure
or insufficient similarity respectively) our approach remains competitive. This
gives assurance that penalization is indeed able to share information appro-
priately in real-world examples. We emphasize that the goal of the empirical
analyses we present is not to give the best predictions possible in these appli-
cations, but rather to explore joint estimation in group-structured biomedical
problems.
2 Methods
2.1 Notation
Each subgroup k ∈ {1 . . .K} has the same set of p covariates, but subgroup-
specific sample size nk. Total sample size is n =
∑K
k=1 nk. For subgroup
k, Xk is the nk × p feature matrix and yk the corresponding nk × 1 vector
of observed responses. Subgroup-specific regression coefficients are βk ∈ Rp.
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Where convenient we collect all regression coefficients together in a p×K matrix
B = [β1 . . . βK ] and accordingly we use βj,k to denote the coefficient for covariate
j in subgroup k.
2.2 Model Formulation
We seek to jointly estimate the regression coefficients B = [β1 . . . βK ] whilst
ensuring global sparsity and encouraging agreement between subgroup-specific
coefficients. We propose the criterion
Bˆ = arg min
B=[β1...βK ]
K∑
k=1
{
‖yk −Xkβk‖22 + λ‖βk‖1 + γ
∑
k′>k
τk,k′‖βk − βk′‖22
}
(1)
and a variant with an `1 norm in the last term
Bˆ = arg min
B
K∑
k=1
{
‖yk −Xkβk‖22 + λ‖βk‖1 + γ
∑
k′>k
τk,k′‖βk − βk′‖1
}
. (2)
Here, λ, γ, τ are tuning parameters. The role of the last term is to encourage
similarity between subgroup-specific regression coefficients. The special case
K = 1 recovers the classical lasso (applied to all data pooled together). The
tuning parameters τk,k′ give the possibility of controlling the extent of fusion
between specific subgroups. By default all τ ’s are set to unity (“unweighted fu-
sion”), but they can also be set to specific values as discussed below (“weighted
fusion”). In the above formulation, we assume that yk and Xk have been stan-
dardized (at the subgroup level) so that no intercept terms are required. Note
that the regularization parameters λ, γ are the same across subgroups.
The difference between the two variants is that the first, `2 fusion encourages
similarity between subgroup-specific coefficients, while the second `1 version al-
lows for exact equality. The `2 formulation has the computational advantage
that the fusion part of the objective function becomes continuously differen-
tiable, and the estimate of the objective function at each step can be obtained
by soft-thresholding, analogously to coordinate descent for regular lasso prob-
lems. In the `1 formulation on the other hand, the fusion constraint is only
piece-wise continuously differentiable, leading to a more difficult optimisation
problem (see below).
2.3 Comparison with group and fused lasso
Our formulation resembles the group lasso and fused lasso, but differs from both
in important ways. The original group lasso [Yuan and Lin, 2006] was designed
to consider groups of covariates within a single regression problem. Let X be the
feature matrix and y the vector of responses in a standard regression problem.
Letting l ∈ {1 . . . L} index groups of covariates, the group lasso criterion is
βˆ = arg min
β
‖y −
L∑
l=1
X(l)β(l)‖22 +
L∑
l=1
λl‖β(l)‖2 (3)
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where X(l) is the submatrix of X corresponding to the covariates in group l,
β(l) the corresponding regression coefficients and λl’s tuning parameters. The
penalty tends to include or exclude all members of a group from the model, i.e.
all coefficients in a group may be set to zero giving groupwise sparsity.
In our setting, the subgroups are subsets of samples rather than covariates.
Nevertheless, as shown in Obozinski et al. [2010], one could use a group lasso-
like criterion for estimation in the multiple subgroup setting by forming groups
l each comprising all the coefficients for a single covariate j ∈ {1 . . . p} across
all K regression problems. This encourages covariates to either be included in
all the subgroup-specific models or none.
The fused lasso [Tibshirani et al., 2005] is also aimed at a single regression
problem, but assumes that the covariates can be ordered in such a way that
successive coefficients may be expected to be similar. This leads to the following
criterion
βˆ = arg min
β
‖y −Xβ‖22 + λ‖β‖1 + γ
p−1∑
i=1
‖βi − βi+1‖1 (4)
where λ, γ are tuning parameters and we have assumed that the covariates are
in a suitable order. The final term encourages similarity between successive
coefficients. Efficient solutions for various classes of this problem exist [e.g.
Hoefling, 2010, Liu et al., 2010, Ye and Xie, 2011].
Our approach shares the use of a fusion-type penalty, but focuses on a dif-
ferent problem, namely that of jointly estimating regression coefficients across
multiple, potentially non-identical, problems. Accordingly, our penalty encour-
ages agreement between entire coefficient vectors from different subgroups and
does not require any ordering of covariates.
2.4 Setting the tuning parameters τ
For weighted fusion, the parameters τk,k′ could be set by cross-validation but
this may be onerous in practice. As an alternative we consider setting τk,k′
using a distance function d(k, k′) based on the covariates. The idea is to allow
more fusion between subgroups that are similar with respect to d, while allowing
the τk,k′ to be set in advance of estimation proper. However, this assumes that
similarity in the covariates reasonably reflects similarity between the underlying
regression coefficients, which may or may not be the case in specific applications.
We consider two variants. The first sets d(k, k′) = ‖µk−µk′‖2 where µk, µk′
are the sample means of the covariates in the subgroups k, k′ respectively (we
assume the data have been standardized). The second approach additionally
takes the covariance structure into account by using the symmetrised Kullback-
Leibler (KL) divergence, i.e. d(k, k′) = 12 (KL(pˆk‖pˆk′) + KL(pˆk′‖pˆk)), where
pˆk, pˆk′ are estimated marginal distributions over the covariates in the subgroups
k, k′ respectively and KL(p‖q) is the KL-divergence between distributions p
and q. In practice, this requires simplifying distributional assumptions. Below
we use multivariate Normal models for this purpose, with the graphical lasso
[Friedman et al., 2008] used to estimate the Σk’s. For both approaches, we set
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τk,k′ = 1 − d(k, k′)/dmax, with dmax the largest distance between any pair of
groups k,k′ (this scales τ to the unit interval).
2.5 Optimisation
We describe a coordinate descent approach for optimising equation (1). While
it is possible to derive a block coordinate descent approach for equation (2)
[e.g. following Friedman et al., 2007], this is generally inefficient for the high-
dimensional problems that we consider. Instead, we will describe an optimiza-
tion procedure based on a proximal gradient approximation derived in Chen
et al. [2010].
2.5.1 Coordinate Descent for `2 Fusion
The `2 fusion penalty is continuously differentiable and we can obtain the opti-
mal value for βˆj,k in equation (1) at each step by first calculating optimal values
without the lasso penalty:
βˆ∗k,j =
xTj,k(yk −X−j,kβ−j,k) + 2γ
∑
k′ 6=k τk,k′βj,k′
xTj,kxj,k + 2γ
∑
k′ 6=k τk,k′
(5)
Then βˆj,k can be obtained by soft-thresholding on βˆ
∗
k,j . The procedure is
summarized in Algorithm 1.
Algorithm 1 Block Coordinate Descent
1: procedure BlockDescentL2(niter, X, Y , βinit, λ, γ, τ)
2: i← 0
3: β ← βinit
4: while not converged AND i < niter do
5: for all j in 1:P do
6: βtempj,1:K ← DescentUpdateL2(X, Y , β, j, γ, τ) using eq. (5)
7: βj,1:K ← sgn(βtempj,1:K) ∗max(βtempj,1:K − λ, 0)
8: i← i+ 1
While Algorithm 1 is easy to understand and implement, a naive implemen-
tation in most programming languages will be still be slow due to the need for
an inner for-loop over p, where p can be in the tens of thousands for the kinds
of problems we will consider. In order to efficiently optimize B, we reformulate
(1) as a classical lasso problem and apply the glmnet software [Friedman et al.,
2010]. We transform the sum in first part of the objective into matrix form
yflat−Xdiagbflat by defining Xdiag as a block-diagonal n× pK matrix with Xk
along the diagonals. The vector bflat is a flattened version of B with stacked
βk vectors, and similarly for yflat. So we have:
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Xdiag =
X1 . . .
XK
 bflat =
β1...
βK
 yflat =
 y1...
yK

Now we move the `2 fusion penalty into the first squared term by defining
the augmented matrix Xaugdiag, and augmented vector y
aug
flat, such that
bˆflat = arg min
bflat
‖yaugflat −Xaugdiagbflat‖22 + λ‖bflat‖1 (6)
where
Xaugdiag =
(
Xdiag
Γ
)
yaugflat =
(
yflat
~0
)
with Γ a pK(K−1)/2×pk matrix encoding the pair-wise fusion constraints, and
~0 a pK(K − 1)/2× 1 vector of zeros. Each block Γk,k′ , k, k′ ∈ [1,K], k < k′ of
p rows of Γ corresponds to the fusion constraint between two coefficient vectors
βk and βk′ , with:
Γk,k′(l,m) =

γτk,k′ if l = p(k − 1) +m
−γτk,k′ if l = p(k′ − 1) +m
0 otherwise.
(7)
We can see that (6) is a classical lasso problem, to which glmnet can be
directly applied.
2.5.2 Proximal-Gradient Approach for Fused L1 Penalty
Optimising equation (2) by block gradient descent, while possible, is highly
inefficient due to having to deal with the discontinuities in the objective function
space. In Chen et al. [2010], the authors describe a proximal relaxation of this
problem that introduces additional smoothing to turn the objective function
fL1(B) into a continuously differentiable function f
µ
L2(B). Chen et al. deal
with the multi-task regression setting (with common X for each task); it is
straightforward to adapt their procedure for the subgroup regression setting
with different Xk per subgroup.
It is notationally convenient to first introduce a graph formulation of the
fusion penalties. We will think of the fusion constraints in terms of an undirected
graph G = (V,E) with vertex set V = {1 . . .K} corresponding to the subgroups
and edges between all vertices. Then the `1 penalised objective function can be
written as:
fL1(B) =
∑
k
{‖yk −Xkβk‖22}+ ‖BC‖1 (8)
where the last term includes both sparsity and fusion penalties, via the matrix
C = (λIK , γH), with IK the identity matrix of size K, C a K × |E| matrix
(|E| = (K2 ) in this case) and Hk,e = τk,l if if e = (m, l) and k = l, Hk,e = −τm,k
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if e = (m, l) and k = l. Note that unlike in Chen et al. [2010], we require the
explicit sum over k in the objective to account for different sample sizes Nk in
different groups1.
The graph formulation allows for zero edges by setting τk,k′ to zero. We
have implicitly assumed in the formulation of (1) and (2) that the relationship
between subgroups is represented by an undirected graph. However, (8) is
completely general, and it would be straightforward to incorporate a directed
graph in our model. We have not pursued this avenue here, as there is no reason
to suspect directionality in the subgroup relationships for the applications we
consider below, and including directionality would double the number of tuning
parameters τk,k′ that need to be considered.
Following Chen et al. [2010], we can introduce an auxiliary matrix A ∈ Q =
{A′| ‖A′‖∞ ≤ 1, A′ ∈ Rp×(K+|E|)}. Because of duality between `1 and `∞, we
can write ‖BC‖1 = max‖A‖∞≤1〈A,BC〉. A smooth approximation of ‖BC‖1 is
then obtained by writing:
fµ(B) = max‖A‖∞≤1
〈A,BC〉 − µd(A) (9)
where µ is a positive smoothness parameter, and d(A) ≡ 12‖A‖2F , with ‖ · ‖F
the Frobenius norm. They show that for a desired accuracy , we need to set
µ = p(K+|E|) . Theorem 1 in Chen et al. [2010] gives the gradient of fµ(B) as
∆fµ(B) = A
∗CT , where A∗ is the optimal solution of (9). Replacing ‖BC‖1 by
fµ(B) in equation (8), we obtain
f˜L1(B) =
∑
k
{‖yk −Xkβk‖22}+ fµ(B) (10)
which is now continuously differentiable with gradient
∆f˜L1(B) =
∑
k
{XTk (XKβk − yk)}+ fµ(B) . (11)
Chen et al. further show that A∗ = S(BC/µ) where function S truncates
each entry of A∗ to the range [-1,1] to ensure that A∗ ∈ Q. An upper bound
LU of the Lipschitz constant L can be derived as:
LU = max
k
(λmax(X
T
k Xk)) +
λ2 + 2 ∗ γ2 maxk∈V dk
µ
(12)
where λmax(M) is the largest eigenvalue of M and dk =
∑K
k′ τk,k′ .
With the derivation of the gradient in (11) and the Lipschitz bound in (12),
we can now apply Nesterov’s method [Nesterov, 2005] for optimizing (10). The
procedure is summarized in Algorithm 2. For more details on the proximal
approach see Chen et al. [2010].
1It would be possible to reformulate the first part of the objective in matrix form Ydiag −
XdiagBdiag by defining Xdiag as a block-diagonal matrix as in Section 2.5.1, defining Bdiag
as a pK ×K matrix with βk along the diagonals and similarly ydiag as an n×K matrix with
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Algorithm 2 Proximal Gradient Optimization
1: procedure Proximal(niter, X, Y , Binit, λ, γ, τ , LU , µ)
2: i← 0
3: W 0 ← Binit
4: while not converged AND i < niter do
5: Compute ∆f˜L1(W
i) according to (11).
6: Bi ←W i − 1LU ∆f˜L1(W i)
7: Zi ← − 1LU
∑i
j=0
j+1
2 ∆f˜L1(W
f )
8: W i+1 ← i+1i+3Bi + 2i+3Zi
9: i← i+ 1
3 Simulation Study
To test the performance of the proposed approach, we simulated data from
a model based on characteristics of a recent cancer dataset, the Cancer Cell
Line Encyclopedia [CCLE; Barretina et al., 2012]. We treat cancer types as
subgroups. To simulate data, we first estimated means and covariance matrices
µk,Σk for each ofK = 9 subgroups (the eight cancer types with the latest sample
sizes in CCLE plus a ninth for all other cancer types; covariances were estimated
using the graphical lasso). For each group k, we then sampled covariates from
the multivariate normal N (µk,Σk). For a given total sample size n, subgroup
sizes were consistent with those in the original data. We used a random subset
of 200 gene expression levels (i.e. the dimensionality was fixed at p = 200).
This parametric approach allowed us to vary sample sizes freely, including the
case of total n larger than in the original dataset. The set-up is intended to
roughly reflect the correlation structure of the covariates, but we do not expect
it to capture all aspects of the real data.
We are interested in the situation in which it may be useful to share infor-
mation between subgroups. But we are also interested in investigating perfor-
mance in settings that do not agree with our model formulation (the extreme
cases being where subgroups are either entirely dissimilar or identical). Let
V = {1 . . .K} be the set of subgroup indices (here, K = 9). We set regression
coefficients to be identical in a subset V0 ⊆ V of the subgroups, such that the
size K0 = |V0| of the subset governs the extent to which fusion could be useful.
Specifically, if K0 = K, all subgroups have the same regression coefficients (i.e.
favoring a pooled analysis using a single regression model) and at the other
extreme if K0 = 1 all groups have differently drawn coefficients. Intermediate
values of K0 give differing levels of similarity.
For a given value K0, we defined membership of V0 by considering the dif-
ferences between the subgroup-specific models for the covariates. Specifically,
we choose the K0 groups that minimized the sum of symmetrised KL diver-
gences between subgroup-specific models. A coefficient vector was then drawn
yk along the diagonals; however, this formulation is neither practical nor intuitive, and the
gain in notational simplicity is negligible.
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separately for each subgroup k /∈ V0 and one, shared coefficient vector drawn
for all k ∈ V0. Each draw was done as follows. We first sampled a binary
vector b of length p from a Bernoulli, i.e. bi ∼ Bernoulli(0.1). Then we drew
βi ∼ Ntrunc(0, 1) if bi = 1 and set βi = 0 otherwise, where Ntrunc(0, 1) de-
notes a standard Normal with the interval (−0.1, 0.1) excluded (this is to ensure
non-zero coefficients are not very small in magnitude). Note that in the case of
K0 = 1, all groups have separately drawn coefficients and the between-subgroup
KL divergence plays no role.
We compare our approaches with pooled and subgroup-wise analyses. These
are performed using classical lasso (we use the glmnet implementation) on re-
spectively the whole dataset or each subgroup separately.
Figure 1 shows performance when varying the number K0 of subgroups with
shared coefficients, with the total number of samples fixed at n = 250. Here,
a smaller value of K0 corresponds to less similarity between subgroup-specific
coefficients in the underlying models. At intermediate values of K0 the fusion
approaches offer gains over pooled and subgroup-wise analyses. This is because
the pooled analyses are mis-specified due to the inhomogeneity of the data, while
the subgroup-wise analyses, although correctly specified, must confront limited
sample sizes since they analyze each subgroup entirely separately. In contrast,
the fusion approaches are able to pool information across subgroups, but also
allow for subgroup-specific coefficients. Importantly, even at the extremes of
K0 = 1 (separately drawn coefficients for each subgroup) and K0 = 9 (all
subgroups have exactly the same coefficients), the fusion approaches perform
well. This demonstrates their flexibility in adapting the degree of fusion.
Figure 2 shows performance as a function of total sample size n. Here, the
number of subgroups with identical coefficients is fixed at K0 = 4. This gives
a relatively weak opportunity for information sharing, since 5/9 groups have
separately drawn coefficients. Since the true βk’s are not identical, the pooled
analysis is mis-specified and accordingly even at large sample sizes, it does
not catch up with the other approaches. As expected, subgroup-wise analyses
perform increasingly well at larger sample sizes. However, at smaller sample
sizes the fusion approaches show some gains.
The `1 and `2 fusion approaches seem similar in performance. Our `2 imple-
mentation leverages the glmnet package and is more computationally efficient
than the `1 approach. For computational convenience, in examples below we
show results from the `2 approach only.
4 Alzheimers disease: prediction of cognitive scores
Here, we use data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
[Mueller et al., 2005] to explore the ability of fusion approaches to estimate
regression models linking clinical and genetic covariates to disease progression,
as captured by cognitive test scores.
In 2014, ADNI made a subset of its data available for a DREAM challenge
[Allen et al., 2016] and we use these data here. The dataset consists of a total
10
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Figure 1: Simulated data, performance for varying K0. Here, the number of
subgroups is fixed at K = 9 of which K0 have shared coefficients in the un-
derlying data-generating model (see text for details of simulation set-up). A
smaller K0 corresponds to less similarity between underlying subgroup-specific
models, with K0 = 1 representing the case where all subgroups have separately
drawn coefficients while K0 = 9 represents an entirely homogenous model in
which each subgroup has exactly the same regression coefficients. The total
sample size is fixed at n = 250. Upper panel: Weighted root mean squared
error (RMSE). RMSE is weighted by subgroup sizes. Lower panel: Area under
the ROC curve (AUROC; with respect to the true sets of active variables with
non-zero coefficients).
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Figure 2: Simulated data, performance at varying sample sizes. Here, the num-
ber of subgroups is fixed at K = 9 of which K0 = 4 have shared coefficients in
the underlying data-generating model (see text for details of simulation set-up).
Top left: Root mean squared error (RMSE; weighted by subgroup sizes). Top
right: Area under the ROC curve (AUROC; with respect to the true sets of
active variables with non-zero coefficients). Bottom: Computational time taken
in log seconds.
of n = 767 individuals who were followed up over at least 24 months. Cognitive
function was evaluated using the mini-mental state examination (MMSE). At
baseline, individuals were classified as either cognitively normal (CN), early mild
cognitive impairment (EMCI), late mild cognitive impairment (LMCI) or diag-
nosed with Alzheimer’s disease (AD). These form clinically-defined subgroups
for our analysis. For the present analysis, we use only genetic data (single nu-
cleotide polymorphisms or SNPs) and clinical profile as covariates and disregard
the neuroimaging data.
The task is to predict the slope of MMSE scores over a 24-month period.
The total number of SNPs available is ∼ 107. Filtering by linkage disequilibrium
reduces this to ∼ 2 × 106. For computational ease, we pre-selected 20,000
of this latter group that gave the smallest residuals when regressed with the
clinical variables against responses in the training set. We note that this biases
our analyses, but we emphasize that our goal in this section is not biomarker
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discovery but comparison between approaches all using the same (pre-selected)
covariates.
Figure 3 shows root mean squared error (RMSE) separately for each of the
four subgroups. The fusion approaches offer substantial gains compared with
pooled and subgroup-wise analyses (the latter performed very badly and are not
shown in the figure). The biggest gain is for the AD subgroup. For the weighted
fusion analysis the tuning parameters τk,k′ were set using the distance between
the means of each subgroup (in the space of genetic and clinical variables).
Weighting did not appear to improve performance.
Figure 4 shows scatter plots of predicted MMSE slopes versus the true slopes.
The predictions shown were obtained in a held-out fashion via 10-fold cross-
validation (CV), as were the RMSE and Pearson correlations shown.
Figure 5 shows a comparison of the estimated regression coefficients them-
selves. The subgroup-wise approach is much sparser than the other methods,
likely due to the fact that it must operate entirely separately on each (rel-
atively small-sample) subgroup. The pooled approach finds more influential
variables but obviously there is no subgroup-specificity. The fused approach
selects more variables than the subgroup-wise analysis, but there are many in-
stances of subgroup-specificity in the estimates.
AD CN EMCI LMCI
0.0
0.2
0.4
0.6
L2 Fusion L2 Fusion
(Weighted)
L2 Fusion L2 Fusion
(Weighted)
L2 Fusion L2 Fusion
(Weighted)
L2 Fusion L2 Fusion
(Weighted)
Cr
os
s−
va
lid
at
ed
 R
M
SE
Method
L2 Fusion
L2 Fusion
(Weighted)
Figure 3: Alzheimers disease prediction results, ADNI data. Box plots showing
difference in RMSE of fused methods compared to the pooled linear regres-
sion model (higher values indicate better performance by the fused methods).
[Subgroup-wise analysis performed less well than pooled and is not shown; box-
plots are over 10-fold cross-validation.]
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Figure 4: Alzheimers disease data, predicted vs. observed responses. Scatter
plots show predicted and observed 24-month slopes for each of the standard
and fused linear regression models. All predictions were obtained via 10-fold
cross-validation.
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Genotype
Clinical
Covariates
Figure 5: Alzheimers disease data, estimated regression coefficients. Heatmap
showing estimated regression coefficients for the clinical variables and a repre-
sentative subsample of the SNPs. Absolute coefficients are thresholded at e−2
to improve readability.
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5 Prediction of therapeutic response in cancer
cell lines
The Cancer Cell Line Encyclopedia [CCLE, Barretina et al., 2012] is a panel
of 947 cancer cell lines with associated molecular measurements and responses
to 24 anti-cancer agents. Here, we use these data to explore group-structured
regression. We treat the area above the dose-response curve as the response
and use expression levels of ∼ 20,000 human genes as covariates. We treat the
cancer types as subgroups k. After discarding cell lines with missing values, we
arrive at n ∼ 500 samples.
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Figure 6: Cancer cell line therapeutic response prediction. Difference in
weighted RMSE between L2 fusion approach and a pooled analysis. Results
shown over 24 responses (anti-cancer agents) using data from the Cancer Cell
Line Encyclopedia (CCLE); the dashed vertical line at zero indicates no differ-
ence, boxplots to the right indicate improvement (lower RMSE) over pooled.
Figure 6 shows results over all 24 responses (anti-cancer agents). We observe
that for most responses the L2 fusion approach shows either improved or similar
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prediction performance to pooled in terms of RMSE (weighted by subgroup
size). Weighted fusion shows a similar performance to unweighted fusion.
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Figure 7: Cancer cell line therapeutic response prediction, broken down by
subgroup (cancer type) for agents PD-0332991 and PLX4720.
Figure 7 shows results broken down by subgroup for two examples (responses
PD-0332991 and PLX4720). In the former case, the fusion approaches largely
outperform pooled and subgroup-wise analyses. In the second, pooled is the
best performer, although the fusion approaches are similar in most subgroups.
6 ALS: prediction of disease progression
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease
that can lead to death within three to four years of onset. However, about ten
percent of patients survive more than 10 years. Prediction of disease progression
remains an open question. We use data from the PROACT database, specif-
ically data that were used in the 2015 DREAM ALS Stratification Prize4Life
Challenge (data were retrieved from the PROACT database on 22/06/2015).
Our aim is not to optimize predictive performance per se but rather to provide
a case study exploring the use of fusion approaches in a moderate-dimensional,
clinical data setting. In contrast to the Alzheimers example above, here the
data are less high-dimensional and the subgrouping less clear cut (see below).
The data consist of observations from n = 2, 393 patients. Each patient was
enrolled in a clinical trial and followed up for a minimum of 12 months after
the start of the trial. Disease progression is captured by a clinical scale called
the ALS Functional Rating Scale (ALSFRS). The task is to predict the slope of
the ALSFRS score from 3 to 12 months (after the start of the trial). For each
patient, available covariates include ALSFRS scores for the 0-3 month period,
demographic information and longitudinal measurements of clinical variables.
We follow the featurization and imputation procedures devised by Mackay [see
Ku¨ffner et al., 2015] and obtain a total of p = 615 covariates.
Subgroups were defined as follows. The first subgroup consists of patients
with disease onset before the start of the trial. The second subgroup consists of
patients for whom onset was after the start of the trial and who have negative
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ALSFRS slope. The third subgroup of patients also had onset after the start
of the trial but positive ALSFRS slope. Thus, the subgroups reflect severity of
onset. As we believe that the pre-trial onset group are likely to differ most from
the others, we manually set the distance between groups 1 and the other two
groups to 1 (the maximum), and set the distance between groups 2 and 3 to
0.1.
Figure 8 shows (held-out) RMSEs by subgroup; we see that the largest im-
provement in prediction performance is in subgroup 1. The fusion approach
leads to a modest improvement. The difference between weighted and un-
weighted fusion is negligible2.
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Figure 8: ALS prediction results. Box plots showing difference in RMSE of
fused methods compared with the pooled linear regression model (higher values
indicate better performance by the fused methods). [Subgroup-wise analysis
performed less well than pooled and is not shown; boxplots are over 10-fold
cross-validation.]
7 Conclusions
Many biomedical datasets are heterogenous, spanning multiple disease types
(or other biological contexts) that are related but also expected to have specific
underlying biology. This means that large datasets are often usefully thought of
as comprising several smaller datasets, that have similarities but that cannot be
assumed to be identically distributed. Statistically efficient regression in these
group-structured settings requires ways to pool information where useful to do
2This dataset is different from the one reported in [Ku¨ffner et al., 2015], with larger vari-
ance in the slopes, and so RMSE values are not directly comparable; however, we note that
performance for our methods compares favorably with that reported in the reference.
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so, whilst retaining the possibility of subgroup-specific parameters and sparsity
patterns. We proposed a penalized likelihood approach for high-dimensional
regression in the group-structured setting that provides group-specific estimates
with global sparsity and that allows for information sharing between groups.
In any given application, even when there are good scientific reasons to
suspect differences in regression models between subgroups, it is hard to know
in advance whether the nature of any differences is such that a specific kind of
joint estimation would be beneficial. For example, if sample sizes are small and
groups only slightly different, pooling may be more effective, or if the groups are
entirely different, fusion of the kind we consider may not be useful. This means
that in practice, either simple pooling or subgroup-wise analysis may be more
effective than fusion. In our approach, the tuning parameter γ (set by cross-
validation) determines the extent of fusion in a data-adaptive manner, and we
saw in several examples that this appears successful in giving results that are
at worst close to the best of pooling and subgroup-wise analyses. For settings
with widely divergent nk’s, it may be important to allow tuning parameters to
depend on nk (we did not do so) and to consider alternative formulations that
allow for asymmetric fusion.
An appealing feature of our approach is that it allows for subgroup-specific
sparsity patterns and parameter estimates that may themselves be of scien-
tific interest. We discussed point estimation, but did not discuss uncertainty
quantification for these subgroup-specific estimates. A number of recent papers
have discussed significance testing for lasso-type models [see e.g. Wasserman
and Roeder, 2009, Lockhart et al., 2014, Sta¨dler and Mukherjee, 2016] and we
think some of these ideas could be used with the models proposed here.
8 Software Availability
The R code used for the experiments in this paper has been made available as R
package fuser on GitHub: https://github.com/FrankD/fuser. Scripts for re-
producing the results in this paper can be obtained at: http://fhm-chicas-code.
lancs.ac.uk/dondelin/SubgroupFusionPrediction.
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